Serum ghrelin levels in patients with Behcet's disease


Erden I., Uçak H., Demir B., Cicek D., BAKAR DERTLİOĞLU S., Aydin S., ...Daha Fazla

Postepy Dermatologii i Alergologii, cilt.33, sa.6, ss.450-456, 2016 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5114/ada.2016.63884
  • Dergi Adı: Postepy Dermatologii i Alergologii
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.450-456
  • Anahtar Kelimeler: Behcet's disease, ghrelin, metabolic syndrome, insulin resistance
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Introduction: Behcet's disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology. Aim: To measure serum ghrelin levels in BD patients and healthy controls and to investigate its association with metabolic syndrome (MetS). Material and methods: Thirty BD patients and 30 healthy individuals were enrolled in the study. Ghrelin levels were measured in blood samples using ELISA. Results: The mean serum ghrelin level in BD patients (28.57 ±14.04) was significantly lower compared to healthy controls (40.72 ±23.21) (p = 0.01). The mean serum ghrelin level in BD patients who had MetS (24.18 ±12.73) was lower compared to BD patients who did not have MetS (30.77 ±14.45), but this difference was not significant (p > 0.05). Conclusions: Ghrelin levels were lower in BD patients compared to healthy controls. There was no association between reduced ghrelin levels and MetS; however, there was a negative correlation between ghrelin levels and disease activity.